Longhorn Vaccines & Diagnostics LLC
1747 Citadel Plaza
9 articles with Longhorn Vaccines & Diagnostics LLC
Longhorn Vaccines & Diagnostics, LLC, a privately held biotechnology company, announced publication of pre-clinical data on the company’s universal influenza vaccine candidate, LHNVD-105, which is a multi-epitope unconjugated influenza composite peptide formulated in collaboration with the U.S. Army’s Liposomal Adjuvant.
Longhorn Vaccines & Diagnostics announced today that it has been selected to deliver a presentation on the past success and future opportunities for its lead product, PrimeStore MTM.
Longhorn Vaccines and Diagnostics LLC, and Greenfield Global Inc. partner to accelerate COVID-19 Testing and Detection
Longhorn Vaccines & Diagnostics, an innovative molecular tool, assay and vaccine development company, and Pharmco, Greenfield Global's popular brand of specialty al
Longhorn Vaccines & Diagnostics and Cenetron Diagnostics Team up with Coca-Cola Bottlers to Produce COVID-19 Test Kits
Longhorn Vaccines & Diagnostics , an innovative molecular tool, assay and vaccine development company focused on serving unmet critical needs in both developed and developing nations, and Cenetron Diagnostics , a cutting-edge clinical research logistics management company, today announced a collaboration with Southeastern Container (SEC), to expand production of COVID-19 testing kits. SEC is a co-o
The conference is the largest gathering of clinicians and public health workers, health program managers, policymakers, researchers and advocates working to end the suffering caused by lung disease with a focus specifically on the challenges faced by low-and lower-middle income populations.
Longhorn Vaccines & Diagnostics LLC Release: PrimeStore Molecular Transport Medium Aiding Laboratories Tracking H7N9 Avian Influenza
Longhorn Vaccines & Diagnostics LLC Announces PrimeStore Molecular Transport Medium Significantly Improves Cepheid Xpert MTB/RIF Sensitivity In Crucial Low Copy Samples
Longhorn Vaccines & Diagnostics LLC's PrimeSuite TB Products Included In The 2015 UNITAID Tuberculosis Diagnostics Technology And Market Landscape
Longhorn Vaccines & Diagnostics LLC Receives FDA Emergency Use Authorization (EUA) for the First 2009 H1N1 Influenza Assay to Include a Molecular Transport Medium (MTM)